James Pursley

James Pursley sells 33,000 HNGE shares for $2.3M via scheduled 10b5-1 plan; stock +27.4% in 30d

James Pursley, President of Hinge Health, executed 3 separate sales totaling 33,000 shares for $2,287,251.28 at a blended average price of $69.31 on 2026-06-22. This transaction is governed by a pre-arranged 10b5-1 trading plan adopted on 2025-06-13, making it scheduled rather than discretionary. Post-transaction, Pursley retains 740,897 shares, representing a 4.3% reduction from his pre-transaction holdings of 773,897 shares. The stock has risen 27.4% over the prior 30 days and 75.1% over the prior 90 days, while his prior sells across all tickers (measured post-sale price movements) averaged +2.1% return at 30 days and +27.7% at 90 days. At the same ticker, his 2 most recent measurable prior sales (2026-03-23) produced 30-day returns of +4.7% and +8.6%, followed by 90-day returns of +62.4% and +68.4%. The company reported latest-quarter revenue of $182,307,000.00 and net income of $35,128,000.00, with annual revenue growth of +50.6%, though full-year net income was negative. This structured sale occurs against a backdrop of strong recent stock appreciation and mixed fundamental signals.

HNGE: President Pursley sells 16,000 shares for $860.6K via scheduled 10b5-1 plan on 2026-05-26

James Pursley, President of Hinge Health, executed three separate sales totaling 16,000 shares for $860,605.72 on 2026-05-26 at blended average price $53.79, reducing his holdings by 2.0% to 780,223 shares post-transaction. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-06-13, meaning the timing and volume were scheduled in advance rather than discretionary. The stock has appreciated +19.0% over the prior 30 days and +22.7% over the prior 90 days; his prior five same-ticker sales at HNGE have all been followed by positive 30-day and 90-day returns (ranging from +0.6% to +8.6% at 30 days, and +23.9% to +42.6% at 90 days). The company reported $182.3M quarterly revenue and $35.1M net income this quarter, but was unprofitable over its most recent full fiscal year despite +50.6% annual revenue growth. As a scheduled transaction under a 10b5-1 plan, this sale reflects pre-committed execution rather than a discretionary decision point.

Hinge Health President Pursley James sells 15,000 shares across 3 transactions for $633,927.32, reducing holdings 2.0%

On 2026-03-23, James executed 3 separate sales totaling 15,000 shares for $633,927.32 at blended average price $42.26, leaving him with 732,104 shares post-transaction. The current stock price of $40.91 is -32.4% from the 52-week high of $60.55, indicating a material pullback from recent peaks. James' prior trades at HNGE show 2 of 2 measurable 90-day outcomes were well-timed (stock declined post-sale), and his cross-ticker track record demonstrates a 100.00% well-timed rate across 7 prior sells with average 90-day returns of -8.8%. Against this backdrop of consistent sell-side timing accuracy, this sale occurs as the company remains unprofitable (net income $-1.8M in latest quarter) despite strong revenue growth of 50.6% year-over-year, a combination that may warrant investor scrutiny of the underlying financial trajectory.

HNGE: President Pursley James sells 15,000 shares ($590.0K) as stock falls 19.9% in 90 days

Pursley James, President of Hinge Health, executed 3 separate sales totaling 15,000 shares for $589,983.62 on 2026-02-23, at an average price of $39.33, reducing his holdings by 2.0%. The stock currently trades at $40.11, down 19.9% over the past 90 days and 33.8% from its 52-week high of $60.55. His cross-ticker track record shows a 100.00% well-timed rate across 4 prior sells (with negative average 90-day returns of -7.6%), and his prior trades at HNGE specifically exhibited a 3 of 3 pattern of well-timed 90-day outcomes; this sale aligns with that historical tendency. The company is currently unprofitable, posting net income of $-1.8M in the latest quarter on $154.2M revenue, which may provide additional context for the executive's disposition.

HNGE President Pursley James sold 15,000 shares at $48.40 on 2025-12-22 ($726.0K); stock now at $48.76 post-trade.

Pursley James, President of Hinge Health, sold 15,000 shares (1.9% of his 784.8K pre-transaction holdings) at $48.40, with the stock currently trading at $48.76 just days after the sale. Across his prior trades at HNGE (three separate sales on 2025-11-21), his 30-day returns ranged from +2.5% to +6.5%, suggesting some modest positive drift in the stock following his prior transactions. The company is profitable at the operating level (recorded a net loss of $-1.8M in the latest quarter), yet his cross-ticker historical track record shows an average 30-day return of +4.1% after his open-market sales, indicating a pattern of selling into periods where the stock subsequently appreciated modestly. The scale of this transaction (1.9% reduction) is not material to his overall position (still holding 769.8K shares), and current price action shows minimal deviation from his execution price.

HNGE President Pursley James sells 15,000 shares for $683.5K at $45.57 avg, retains 789.9K shares.

President James Pursley executed 3 separate sales totaling 15,000 shares for $683,486.77 on 2025-11-21, at a blended average price of $45.57. The current price of $47.01 is 22.4% below the 52-week high of $60.55, and the stock has declined 5.2% over the past 30 days and 14.7% over 90 days, suggesting headwinds in the trading environment. Pursley retains substantial holdings of 789,902 shares post-transaction, representing 98.1% of prior holdings, indicating continued significant stake in the company. The sale occurred as HNGE posted a net loss of $1,844,000 in the latest quarter despite $154,211,000 in revenue, signaling operational challenges that warrant monitoring.